Ondine Biomedical, Inc.(DE:VF5)
€0.09+0.00 (+4.71%)
DE:VF5
Ondine Biomedical, Inc. Revenue
€0.09
At close:+0.00 (+4.71%)
Ondine Biomedical, Inc. (VF5) Revenue
2 Followers
Ondine Biomedical, Inc. Revenue
Ondine Biomedical, Inc. had a revenue of 1.23M in the quarter ending Jun 30, 2026, with -24.28%. This bring the company's revenue in the last twelve months to 2.85M, Increased 7.11%. In the fiscal year ending Dec 31, 2025, Ondine Biomedical, Inc. had annual revenue of 2.65M with 29.45% growth.
- Revenue (ttm)
- 2.85M
- Revenue Growth
- 22.75%
- P/S Ratio
- 27.74
- Revenue/Employee
- EUR 147,357
- Employees
- 18
- Market Cap
- EUR 73.58M
Revenue Chart
Ondine Biomedical, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.65M | 603.43K | 29.45% |
| Dec 31, 2024 | 2.05M | 846.00K | 70.32% |
| Dec 31, 2023 | 1.20M | 565.00K | 88.56% |
| Dec 31, 2022 | 638.00K | -1.93M | -75.17% |
| Dec 31, 2021 | 2.57M | 778.00K | 43.44% |
| Dec 31, 2020 | 1.79M | 1.33M | 285.99% |
| Dec 31, 2019 | 464.00K | 91.00K | 24.40% |
| Dec 31, 2018 | 373.00K | -39.00K | -9.47% |
| Dec 31, 2017 | 412.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.